李寧(02331.HK)漲近7%重越97元 惟361度(01361.HK)跌近7%
李寧(02331.HK)自從中績多賺近1.9倍至19.62億人民幣曝光後獲多間大行升價至99.8-119元不等,其中麥格理及大摩目標價最進取分別為119元及113元,匯豐研究目標價最保守僅99.8元。該股連續四天跑贏,今早高見97.3元,半日收97.15元,升6.8%,半日成交已達1,435萬股。
斥4.4億人民幣購商用物業用作上海營運中心的特步國際(01368.HK)反覆回升1.5%半日收11.74元。
相反,昨午公布中績多賺33%至4.01億人民幣的361度(01361.HK)扭兩連升重失10天及20天線(3.43元),最低見3.21元,半日收3.31元,逆跌6.8%,半日成交539萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.